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E D I T O R I A L

ISTH 2017 Berlin revisited
The ISTH Congress 2017 in Berlin attracted more than 9500 participants from 110 countries, bringing together physicians and researchers in the largest global meeting of the thrombosis and hemostasis field this year (Figure) . This congress in one of Europe's most dynamic and attractive cities featured 131 invited speakers, including eight plenary presentations and 84 state-of-the-art lectures by leaders in our disciplines. The congress also presented 39 scientific abstract symposia with an introductory review lecture, followed by oral presentations of top-scoring abstracts related to these timely topics in thrombosis and hemostasis research. This central international meeting of our disciplines covered all aspects from basic science to clinical practice related to bleeding disorders and thrombosis. In addition to the ground-breaking advances in thrombosis and hemophilia therapy, These and forthcoming reviews to be published in RPTH document the rapid progress across scientific boundaries and reflect the broad technological and scientific innovation that continues to transform thrombosis and hemostasis research. Several of the reviews are focused on the increasingly appreciated interactions of the hemostatic system with inflammation and immunity. The deeper understanding of how multi-cellular interactions contribute to thrombo-inflammatory disorders will eventually drive innovations in diagnosis and therapy of acquired bleeding disorders and thrombosis. Genetic advances will impact not only the diagnosis of bleeding disorders, but are key drivers for epidemiological and outcome studies in thrombosis research. The impact of these areas of intense current research on clinical practice, diagnosis, and therapy will be highlighted in several reviews.
We hope that this review series in the newly launched RPTH will fill an existing gap in providing a timely communication of new developments. This format should be well suited for international exchange in our active and vibrant field with many opportunities for young investigators in the future.
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